Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

University of California, Davis · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
recurrent diffuse large b-cell lymphoma, refractory diffuse large b-cell lymphoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 804017
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.